Effects of bortezomib on bone disease in multiple myeloma.
Drake
Matthew T
MT
Division of Endocrinology and Metabolism, College of Medicine, Mayo Clinic, Rochester, MN 55905, USA.
Rajkumar
S Vincent
SV
D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001897:Boronic Acids / Q000627:therapeutic use*; D000069286:Bortezomib; D004195:Disease Models, Animal; D006801:Humans; D051379:Mice; D009101:Multiple Myeloma / Q000150:complications / Q000188:drug therapy*; D010010:Osteoclasts / Q000187:drug effects*; D010014:Osteolysis / Q000188:drug therapy* / Q000209:etiology; D011719:Pyrazines / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D001897:Boronic Acids; D011719:Pyrazines; D000069286:Bortezomib